Aspirin resistance: a revival of platelet aggregation tests? (Q28208759)

https://api.crossref.org/works/10.1046/J.1538-7836.2003.00354.X

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1538-7836.2003.00354.X

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1538-7836.2003.00354.X

Effect of ibuprofen on cardioprotective effect of aspirin

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1538-7836.2003.00354.X

Might proton pump inhibitors prevent the antiplatelet effects of low- or very low-dose aspirin?

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1538-7836.2003.00354.X

Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1538-7836.2003.00354.X

Genetic variation in cyclooxygenase 1: effects on response to aspirin

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1538-7836.2003.00354.X

Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1538-7836.2003.00354.X

Arachidonic acid metabolism by human monocytes. Studies with platelet-depleted cultures

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1538-7836.2003.00354.X

Role of prostacyclin in the cardiovascular response to thromboxane A2

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1538-7836.2003.00354.X

Epinephrine--via activation of p38-MAPK--abolishes the effect of aspirin on platelet deposition to collagen

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1538-7836.2003.00354.X

Effects of salicylates on human platelets.

20 April 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Ibuprofen protects platelet cyclooxygenase from irreversible inhibition by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

The influence of platelet collagen receptor polymorphisms in hemostasis and thrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of eryt

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Increased synthesis of thromboxane A(2) and expression of procoagulant activity by monocytes in response to arachidonic acid in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Low dose aspirin does not prevent fibrinolytic response to venous occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Cigarette Smoking Acutely Increases Platelet Thrombus Formation in Patients With Coronary Artery Disease Taking Aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Aspirin resistance:a new independent predictor of vascular events?**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do no necessarily represent the views of JACCor the American College of

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Pharmacologic modulation of arachidonic acid metabolism in man. A minireview with emphasis on radioimmunological methods used to quantitate drug effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Aspirin resistance and genetic polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Cyclooxygenases-1 and −2 of Endothelial Cells Utilize Exogenous or Endogenous Arachidonic Acid for Transcellular Production of Thromboxane

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Habitual smoking causes an abnormality in platelet thromboxane A2 metabolism and results in an altered susceptibility to aspirin effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X

Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1538-7836.2003.00354.X